Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Perlman

Showing results (191-200 of 275) with videos related to

Pageof 28
Sort By:
Nature Communications|November 23, 2016
Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccinesLanying Du, Wanbo Tai, Yang Yang, et al.
Mbio|January 25, 2022
N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune RecognitionRuangang Pan, Eveline Kindler, Liu Cao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2014
Rapid generation of a mouse model for Middle East respiratory syndromeJincun Zhao, Kun Li, Christine Wohlford-Lenane, et al.
Plos Pathogens|May 18, 2026
Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escapeFan Bu, Divyasha Saxena, Hailey Turner-Hubbard, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunityCollin D Heer, Daniel J Sanderson, Lynden S Voth, et al.
Cellular & Molecular Immunology|February 3, 2015
Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirusNaru Zhang, Rudragouda Channappanavar, Cuiqing Ma, et al.
The Journal of Biological Chemistry|October 14, 2020
Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunityCollin D Heer, Daniel J Sanderson, Lynden S Voth, et al.
Elife|August 2, 2021
The development of <i>Nanosota</i>-<i>1</i> as anti-SARS-CoV-2 nanobody drug candidatesGang Ye, Joseph Gallant, Jian Zheng, et al.
Emerging Microbes & Infections|May 28, 2019
Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infectionWenxu Jia, Rudragouda Channappanavar, Chao Zhang, et al.
Mbio|May 3, 2018
Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon ResponsesJeremiah Athmer, Anthony R Fehr, Matthew E Grunewald, et al.
Pageof 28

Showing results (191-200 of 275) with videos related to

Sort By:
Pageof 28
Nature Communications|November 23, 2016
Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccinesLanying Du, Wanbo Tai, Yang Yang, et al.
Mbio|January 25, 2022
N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune RecognitionRuangang Pan, Eveline Kindler, Liu Cao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2014
Rapid generation of a mouse model for Middle East respiratory syndromeJincun Zhao, Kun Li, Christine Wohlford-Lenane, et al.
Plos Pathogens|May 18, 2026
Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escapeFan Bu, Divyasha Saxena, Hailey Turner-Hubbard, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunityCollin D Heer, Daniel J Sanderson, Lynden S Voth, et al.
Cellular & Molecular Immunology|February 3, 2015
Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirusNaru Zhang, Rudragouda Channappanavar, Cuiqing Ma, et al.
The Journal of Biological Chemistry|October 14, 2020
Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunityCollin D Heer, Daniel J Sanderson, Lynden S Voth, et al.
Elife|August 2, 2021
The development of <i>Nanosota</i>-<i>1</i> as anti-SARS-CoV-2 nanobody drug candidatesGang Ye, Joseph Gallant, Jian Zheng, et al.
Emerging Microbes & Infections|May 28, 2019
Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infectionWenxu Jia, Rudragouda Channappanavar, Chao Zhang, et al.
Mbio|May 3, 2018
Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon ResponsesJeremiah Athmer, Anthony R Fehr, Matthew E Grunewald, et al.
Pageof 28